222 related articles for article (PubMed ID: 9844766)
1. Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean fever.
Kiraz S; Ertenli I; Arici M; Calgüneri M; Haznedaroglu I; Celik I; Pay S; Kirazli S
Clin Exp Rheumatol; 1998; 16(6):721-4. PubMed ID: 9844766
[TBL] [Abstract][Full Text] [Related]
2. Increased asymmetric dimethylarginine levels in young men with familial Mediterranean fever (FMF): is it early evidence of interaction between inflammation and endothelial dysfunction in FMF?
Terekeci HM; Oktenli C; Ozgurtas T; Nalbant S; Top C; Celik S; Tapan S; Kucukardali Y; Sanisoglu YS; Solmazgul E; Sahan B; Sayan O
J Rheumatol; 2008 Oct; 35(10):2024-9. PubMed ID: 18785307
[TBL] [Abstract][Full Text] [Related]
3. Can the Thiol/Disulfide Imbalance Be a Predictor of Colchicine Resistance in Familial Mediterranean Fever?
Omma A; Sandikci SC; Kücüksahin O; Alisik M; Erel O
J Korean Med Sci; 2017 Oct; 32(10):1588-1594. PubMed ID: 28875601
[TBL] [Abstract][Full Text] [Related]
4. Update on the management of colchicine resistant Familial Mediterranean Fever (FMF).
El Hasbani G; Jawad A; Uthman I
Orphanet J Rare Dis; 2019 Oct; 14(1):224. PubMed ID: 31615541
[TBL] [Abstract][Full Text] [Related]
5. Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients.
Baykal Y; Saglam K; Yilmaz MI; Taslipinar A; Akinci SB; Inal A
Clin Rheumatol; 2003 May; 22(2):99-101. PubMed ID: 12740672
[TBL] [Abstract][Full Text] [Related]
6. The Value of Serum Amyloid A Levels in Familial Mediterranean Fever to Identify Occult Inflammation During Asymptomatic Periods.
Çakan M; Karadağ ŞG; Tanatar A; Sönmez HE; Ayaz NA
J Clin Rheumatol; 2021 Jan; 27(1):1-4. PubMed ID: 31524848
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil-lymphocyte ratio in patients with familial Mediterranean fever.
Celikbilek M; Dogan S; Akyol L; Borekci E; Zararsiz G; Kozan M; Gunaydin I
J Clin Lab Anal; 2015 Jan; 29(1):80-3. PubMed ID: 24687426
[TBL] [Abstract][Full Text] [Related]
8. Effects of anti-tumor necrosis factor agents for familial mediterranean fever patients with chronic arthritis and/or sacroiliitis who were resistant to colchicine treatment.
Bilgen SA; Kilic L; Akdogan A; Kiraz S; Kalyoncu U; Karadag O; Ertenli I; Dogan I; Calguneri M
J Clin Rheumatol; 2011 Oct; 17(7):358-62. PubMed ID: 21946459
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of hearing in pediatric familial Mediterranean fever patients during attack period and attack-free period.
Salimov A; Akyol U; Cildir B; Batu ED; Ozen S
Int J Pediatr Otorhinolaryngol; 2019 Apr; 119():185-192. PubMed ID: 30743166
[TBL] [Abstract][Full Text] [Related]
10. Is there a relationship between serum omentin level and acute phase response in patients with familial Mediterranean fever?
Can Sandikci S; Omma A; Yucel C; Omma T
Clin Rheumatol; 2021 Feb; 40(2):669-674. PubMed ID: 32623649
[TBL] [Abstract][Full Text] [Related]
11. Anti-interleukin-1 treatment in 26 patients with refractory familial mediterranean fever.
Kucuksahin O; Yildizgoren MT; Ilgen U; Ates A; Kinikli G; Turgay M; Erten S
Mod Rheumatol; 2017 Mar; 27(2):350-355. PubMed ID: 27328763
[TBL] [Abstract][Full Text] [Related]
12. The significance of urinary beta-2 microglobulin level for differential diagnosis of familial Mediterranean fever and acute appendicitis.
Ugan Y; Korkmaz H; Dogru A; Koca YS; Balkarlı A; Aylak F; Tunc SE
Clin Rheumatol; 2016 Jul; 35(7):1669-72. PubMed ID: 26873102
[TBL] [Abstract][Full Text] [Related]
13. Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.
Eroglu FK; Beşbaş N; Topaloglu R; Ozen S
Rheumatol Int; 2015 Oct; 35(10):1733-7. PubMed ID: 26001859
[TBL] [Abstract][Full Text] [Related]
14. Activation of the cytokine network in familial Mediterranean fever.
Gang N; Drenth JP; Langevitz P; Zemer D; Brezniak N; Pras M; van der Meer JW; Livneh A
J Rheumatol; 1999 Apr; 26(4):890-7. PubMed ID: 10229412
[TBL] [Abstract][Full Text] [Related]
15. Is Familial Mediterranean Fever a thrombotic disease or not?
Demirel A; Celkan T; Kasapcopur O; Bilgen H; Ozkan A; Apak H; Arisoy N; Yildiz I
Eur J Pediatr; 2008 Mar; 167(3):279-85. PubMed ID: 17436016
[TBL] [Abstract][Full Text] [Related]
16. The anemia of familial Mediterranean fever disease.
Celkan T; Celik M; Kasapçopur O; Ozkan A; Apak H; Ocak S; Arisoy N; Yildiz I
Pediatr Hematol Oncol; 2005 Dec; 22(8):657-65. PubMed ID: 16251171
[TBL] [Abstract][Full Text] [Related]
17. Decreased vitamin D levels in children with familial Mediterranean fever.
Anık A; Catlı G; Makay B; Abacı A; Küme T; Unsal E; Böber E
Int J Rheum Dis; 2014 Mar; 17(3):321-6. PubMed ID: 24410734
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) in familial Mediterranean fever.
Başar O; Oztürk MA; Köklü S; Ayaz S; Yüksel O; Kiraz S; Ertenli I; Calgüneri M
Joint Bone Spine; 2007 Jan; 74(1):52-5. PubMed ID: 17223601
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo PBMC cytokine profile in familial Mediterranean fever patients: Involvement of IL-1β, IL-1α and Th17-associated cytokines and decrease of Th1 and Th2 cytokines.
Ibrahim JN; Jounblat R; Delwail A; Abou-Ghoch J; Salem N; Chouery E; Megarbane A; Medlej-Hashim M; Lecron JC
Cytokine; 2014 Oct; 69(2):248-54. PubMed ID: 25025954
[TBL] [Abstract][Full Text] [Related]
20. Enhanced cytokine mRNA levels in attack-free patients with familial Mediterranean fever.
Notarnicola C; Didelot MN; Seguret F; Demaille J; Touitou I
Genes Immun; 2002 Feb; 3(1):43-5. PubMed ID: 11857061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]